ppe1 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
ppe1 antibody; esp1 antibody; ppx1 antibody; SPCC1739.12 antibody; Serine/threonine-protein phosphatase ppe1 antibody; EC 3.1.3.16 antibody; Phosphatase esp1 antibody
Target Names
ppe1
Uniprot No.

Target Background

Function
Ppe1 antibody plays a crucial role in chromosome segregation. It may function as a dynamic link between kinetochore microtubules and kinetochore chromatin. Additionally, it negatively regulates the mis12 protein.
Gene References Into Functions
  1. Regulation of Hmg1 phosphorylation is dependent on the protein phosphatase 2A-related phosphatase Ppe1 and its regulatory protein Sds23. PMID: 21680738
Database Links
Protein Families
PPP phosphatase family, PP-6 (PP-V) subfamily
Subcellular Location
Nucleus. Note=Associated with chromatin.

Q&A

What is ppe1 and why are antibodies against it important in research?

Ppe1 (also known as PP6 phosphatase) plays a critical role in equal chromosome segregation during cell division. Antibodies against ppe1 are essential tools for investigating its functional interactions, subcellular localization, and activity regulation. Research indicates that Ppe1 forms a complex with Ekc1 protein and is functionally connected to chromosome segregation mechanisms . These antibodies enable researchers to monitor ppe1's behavior across different experimental conditions, providing insights into its role in maintaining genomic stability.

What are the optimal conditions for using ppe1 antibodies in immunoprecipitation?

For successful immunoprecipitation of ppe1, polyclonal antibodies have demonstrated significant efficacy. Based on experimental protocols, approximately 20% of total Ppe1 can be successfully precipitated using anti-Ppe1 antibodies under standard conditions . The optimal buffer composition typically includes mild detergents to preserve protein-protein interactions. When co-precipitating ppe1 with interacting partners like Ekc1-Myc, researchers should maintain physiological salt concentrations (150mM NaCl) to preserve the integrity of protein complexes. The immunoprecipitation technique has successfully demonstrated that Ekc1 stably binds to Ppe1, though no direct binding to Mis12 was detected under the same experimental conditions .

How can I validate the specificity of ppe1 antibodies?

Multiple validation approaches should be employed to ensure antibody specificity:

  • Knockout/knockdown controls: Compare antibody signals between wild-type samples and those where ppe1 expression has been eliminated or reduced.

  • Peptide competition assays: Pre-incubation of the antibody with the immunizing peptide should abolish specific signals.

  • Cross-reactivity testing: Examine reactions with related phosphatases, particularly other PP family members.

  • Multiple techniques validation: Confirm consistent results across immunoblotting, immunofluorescence, and immunoprecipitation.

Research indicates that well-validated anti-Ppe1 antibodies can effectively co-precipitate approximately 20% of Ekc1-Myc protein, demonstrating their utility in studying protein-protein interactions .

How can I determine ppe1 localization using antibodies when direct immunofluorescence is challenging?

When direct immunofluorescence using anti-ppe1 antibodies proves difficult (as noted in published research ), alternative approaches include:

  • Epitope tagging strategies: Create functional tagged versions of ppe1 (validating that functionality is maintained). Research has shown that GFP-tagging of ppe1 can reveal nuclear and chromatin localization, though functional verification is crucial as some C-terminal GFP fusions have demonstrated cold-sensitivity and cell shape defects .

  • Domain-specific localization: Studies have demonstrated that the N-terminus of Ppe1 (amino acids 1-94) tagged with GFP targets to chromatin similar to full-length protein, suggesting this domain contains localization signals .

  • Co-localization with known interactors: Use antibodies against confirmed binding partners like Ekc1, which has been shown to be enriched in the nucleus and associated with chromatin .

  • Fixed-cell analysis optimization: Modify fixation protocols to preserve epitope accessibility while maintaining cellular architecture.

ApproachAdvantagesLimitationsPublished Evidence
GFP taggingDirect visualization in live cellsMay affect protein functionShows nuclear chromatin enrichment
N-terminal domain taggingMinimizes functional disruptionMay miss regulatory elementsDemonstrates chromatin targeting
Interactor co-localizationValidates interactions in situIndirect localization inferenceEkc1-YFP shows nuclear enrichment

What methodologies can detect conformational changes in ppe1 during cell cycle progression?

To investigate ppe1 conformation changes throughout the cell cycle:

  • Cell cycle-synchronized sampling: Employ techniques like thymidine block or mitotic shake-off to isolate cells at specific cycle phases.

  • Phosphorylation-specific antibodies: Develop or utilize antibodies that recognize post-translationally modified forms of ppe1.

  • Proximity labeling techniques: Use BioID or APEX2 fusions to map differential interactomes across cell cycle stages.

  • FRET-based sensors: Develop fluorescent biosensors that detect ppe1 conformational shifts.

Research indicates that Ekc1, a binding partner of ppe1, exhibits different localization patterns between interphase (closely resembling nuclear chromatin) and mitosis (diffuse nuclear signal), suggesting potential cell cycle-dependent regulation of the ppe1-Ekc1 complex . This observation provides a foundation for investigating similar dynamics in ppe1 itself.

How can ppe1 antibodies help elucidate the functional counterbalance between ppe1 phosphatase and Gsk3 kinase?

Experimental approaches to study this counter-regulatory relationship include:

  • Co-immunoprecipitation with activity assays: Combine ppe1 antibody immunoprecipitation with phosphatase activity measurements in the presence/absence of Gsk3.

  • Substrate phosphorylation mapping: Identify shared substrates using antibodies against ppe1 and Gsk3, followed by phosphoproteomic analysis.

  • Genetic interaction analysis: Research has shown that moderate overproduction of Gsk3 inhibits colony formation in ekc1 or ppe1 mutant cells, while requiring intense overexpression for wild-type inhibition, suggesting a functional counterbalance between these enzymes .

  • Phenotypic rescue assays: Document how antibody-mediated inhibition of ppe1 affects cellular phenotypes and whether these effects can be modulated by Gsk3 manipulation.

Research demonstrates that cells with intense Gsk3 expression become round in shape, similar to ekc1- and ppe1-defective mutant cells, providing further evidence of their opposing functions .

How can researchers address non-specific binding when using ppe1 antibodies?

Non-specific binding represents a significant challenge when working with phosphatase antibodies like those against ppe1:

  • Blocking optimization: Systematic testing of different blocking agents (BSA, milk, commercial blockers) at various concentrations.

  • Antibody titration: Determine the minimum effective concentration to reduce background.

  • Pre-adsorption strategies: Pre-incubate antibodies with cell lysates from ppe1-knockout lines to deplete cross-reactive antibodies.

  • Sequential epitope exposure: For complex samples, employ epitope retrieval methods that maximize specific binding while minimizing non-specific interactions.

  • Validation across techniques: Compare antibody performance in Western blot, immunoprecipitation, and immunofluorescence to identify technique-specific optimization needs.

What experimental approaches can distinguish between direct and indirect interactions of ppe1 with other proteins?

To differentiate direct from indirect protein interactions:

  • In vitro binding assays: Use purified recombinant proteins with anti-ppe1 antibodies to detect direct interactions.

  • Proximity ligation assays: Employ in situ techniques to visualize protein proximity at the subcellular level.

  • Crosslinking immunoprecipitation: Apply graduated crosslinking followed by immunoprecipitation with ppe1 antibodies.

  • Yeast two-hybrid screening: Validate interactions identified through co-immunoprecipitation experiments.

Research demonstrates that while Ekc1 stably binds to Ppe1 (with 20% co-precipitation), Mis12 protein was not detected in precipitates with either anti-Ppe1 or anti-Ekc1-Myc antibodies under standard experimental conditions , illustrating how antibody-based approaches can distinguish interaction patterns.

How can ppe1 antibodies be employed to investigate chromosome segregation defects?

Ppe1 antibodies represent powerful tools for studying chromosome segregation mechanisms:

  • Chromatin immunoprecipitation (ChIP): Use ppe1 antibodies to identify chromatin-association patterns at different cell cycle stages.

  • Live-cell imaging combined with immunofluorescence: Correlate dynamic chromosome behaviors with ppe1 localization.

  • Sequential immunoprecipitation: Identify multi-protein complexes involving ppe1 at kinetochores during mitosis.

  • Phosphoproteome analysis: Compare phosphorylation profiles between wild-type cells and those with ppe1 mutations using phospho-specific antibodies.

The functional link between Ppe1–Ekc1 and kinetochore represents a novel aspect of chromosome segregation regulation worth investigating through antibody-based approaches .

What controls are essential when comparing antibody reactivity patterns across different experimental systems?

When comparing antibody reactivity across experimental systems, essential controls include:

  • Loading and transfer controls: Use total protein staining methods to ensure equivalent sample processing.

  • Epitope accessibility verification: Confirm that different sample preparation methods maintain epitope recognition.

  • Cross-reactivity profiling: Test antibodies against related proteins to establish specificity boundaries.

  • Validation across species: When working with conserved proteins like phosphatases, verify antibody performance in each species.

  • Batch consistency testing: Maintain reference samples to normalize between antibody lots.

This methodological rigor is particularly important when studying evolutionary conserved proteins like phosphatases, which may share significant sequence homology across family members.

How do methodological approaches for ppe1 antibodies compare with those used for other phosphatase antibodies?

Phosphatase antibody research shares common challenges but requires protein-specific optimization:

  • Epitope selection considerations: Phosphatases often contain highly conserved catalytic domains but divergent regulatory regions, affecting antibody specificity.

  • Activity-state detection: Unlike ppe1 antibodies, some phosphatase antibodies can discriminate between active and inactive conformations through specific epitope recognition.

  • Cross-reactivity management: Systematic testing against related phosphatases is essential for all phosphatase antibodies.

  • Application-specific protocols: While immunoprecipitation protocols may share common elements across phosphatases, immunofluorescence conditions typically require protein-specific optimization.

Antibody approaches used successfully for ppe1, such as co-immunoprecipitation with interacting partners and subcellular localization studies , provide methodological frameworks that can be adapted for other phosphatase research.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.